Johnson & Johnson (JNJ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Johnson & Johnson | JNJ | Healthcare | Drug Manufacturers - General | 97 | 9.0% |
| Current Price ( 5/26 4:00PM EDT) | $154.35 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 96,263.0 | |||
| Sales Growth Forecast | 4.0% | |||
| Net Profit Margin | 28.8% | |||
| Projected Shares Outstanding | 2,554.25 | |||
| EPS - Five year Forecast | $13.20 | |||
| Average P/E Ratio | 16.0 | |||
| Projected Average Price | $211.23 | |||
| Price Appreciation (Annualized) | 6.5% | |||
| Annual Dividend Yield | 2.5% | |||
| Projected Annual Return | 9.0% | |||
| Quality | ||||
| Financial Strength | 100 | 24.9 | ||
| EPS Stability | 91 | 22.9 | ||
| Industry Sales Growth Rate | 4.0% | 12.5 | ||
| Industry Net Profit Margin | 19.3% | 18.7 | ||
| Calculated Quality Rating | 78.9 | |||
| Fool CAPS | ||||
Total Players
13610
Outperforms
514
Underperforms
All-Stars (2591)
2529
Outperforms (98%)
62
Underperforms
|
||||
| Fundamental Data Updated: 05/12/2023 | ||||